7487 Results

People

  1. Brennan
    Brennan
  2. Danishefsky
    Danishefsky
  3. Larson
    Larson
  4. Scheinberg
    Scheinberg
  5. Fuks
    Fuks
  6. Rosen
    Rosen
  7. Hricak
    Hricak
  8. Pasternak
    Pasternak
  9. Sadelain
    Sadelain
  10. Scardino
    Scardino

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)
  7. Radiology, Department of (1814)
  8. Hematologic Malignancies Research (1617)
  9. Hematologic Malignancies, Division of (1517)
  10. Center for Molecular Imaging and Biotechnology (1341)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Crystal structures of the c-Abl tyrosine kinase domain in complex with STI-571 and a novel Bcr-Abl inhibitor, PD173955
    Meeting Abstract

    Swendeman, S.; Nagar, B.; Wisniewski, D.; Strife, A.; Lambek, C.; Liu, C.; Veach, D.; Bornmann, W.; Kuriyan, J.; Clarkson, B.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Development of 9-alkyl-8-benzyl-9H-purin-6-ylamines as inhibitors of the hsp90 family
    Meeting Abstract

    Chiosis, G.; Shtil, A.; Lucas, B.; Huezo, H.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • 17-Allylamino-geldanamycin causes AKT inactivation and enhances the anti-tumor effects of paclitaxel
    Meeting Abstract

    Solit, D. B.; Basso, A. D.; Munster, P. N.; Norton, L.; Scher, H. I.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces differentiation of human breast cancer cells
    Meeting Abstract

    Munster, P. N.; Rosen, N.; Rifkind, R.; Marks, P.; Richon, V.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Phase I trial of 17AAG (17-allylamino) 17-demethoxygeldanamycin (17AAG) in patients (Pts) with advanced cancer
    Meeting Abstract

    Scher, H. I.; Solit, D. B.; Munster, P. N.; Tong, W. P.; Lawrence, S.; Kenneson, K.; Larson, S.; De La Cruz, A.; Reuter, V.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • All CML patients vaccinated with a multivalent bcr-abl peptide vaccine show specific immune responses in a phase II trial
    Meeting Abstract

    Cathcart, K.; Pinilla-Ibarz, J.; Korontsvit, T.; Rodrigues, E.; Schwartz, Y.; Lai, L.; Hossain, M.; Papadopoulos, E.; Scheinberg, D. A.
    Blood (2001)

    Fulltext@MSK | Save
  • Generation of specific T cell immune responses to AML1/ETO in t(8;21) acute myeloid leukemia
    Meeting Abstract

    Dasgupta, B.; Pinilla-Ibarz, J.; Roberts, W.; Moldenhauer, A.; Schwartz, J.; Rodrigues, E.; Korontsvit, T.; Nimer, S. D.; Scheinberg, D. A.
    Blood (2001)

    Fulltext@MSK | Save
  • Long term survival of SCID-beige mice bearing Raji cell tumors after intravenous treatment with human T cells genetically modified to recognize the CD19 antigen
    Meeting Abstract

    Brentjens, R. J.; Gong, M. C.; Latouche, J. B.; Riviere, I.; Sadelain, M.
    Blood (2001)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide: A new active regimen for patients with fludarabine refractory CLL
    Meeting Abstract

    Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Horgan, D. E.
    Blood (2001)

    Fulltext@MSK | Save
  • Primary tumor cells expressing human telomerase reverse transcriptase (hTERT) are killed by specific human cytotoxic T lymphocytes generated using artificial antigen presenting cells
    Meeting Abstract

    Dupont, J.; Latouche, J. B.; Sadelain, M.
    Blood (2001)

    Fulltext@MSK | Save